过去一年中添加的文章，按日期排序
Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in Gastric Cancer Cells
JY Jung, SA Koh, KH Lee - Anticancer Research, 2024 - ar.iiarjournals.org
70 天前 - … The aim of this study was to investigate the effect of hepatocyte growth factor (HGF)-…
on vascular endothelial growth factor (VEGF) expression and its role in gastric cancer cell …
on vascular endothelial growth factor (VEGF) expression and its role in gastric cancer cell …
[HTML][HTML] Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept
M Wishahi - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
88 天前 - … , metastatic, and recurrent cancer in the liver, gastrointestinal … Erdafitinib is a
fibroblast growth factor receptor (FGFR) … cancer immunotherapy as first-line treatment in invasive …
fibroblast growth factor receptor (FGFR) … cancer immunotherapy as first-line treatment in invasive …
Emerging and reemerging human fungal pathogens that affect people with weakened immune systems: a systematic review
91 天前 - … asthma, hepatic cirrhosis, cancer, diabetes, cystic fibrosis (CF), transplant recipients,
and chronic obstructive pulmonary disease (COPD). Climate change, agricultural activities, …
and chronic obstructive pulmonary disease (COPD). Climate change, agricultural activities, …
Evaluation of FibraChek™ for non-invasive detection of hepatic fibrosis and hepatocellular carcinoma
101 天前 - … Introduction and Objectives: The incidence of hepatocellular carcinoma (HCC) has
… of cancer-related deaths. Advanced liver fibrosis and cirrhosis are ones of major risk factors …
… of cancer-related deaths. Advanced liver fibrosis and cirrhosis are ones of major risk factors …
Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1/TNNC1 axis
L Li, G Zhu, C Gong, M Hu, K Tan, L Jiang… - … and Redox Signaling, 2024 - liebertpub.com
104 天前 - … Aimed at further investigating the underlying mechanism of the E2F1/TNNC1 axis
in HCC, we predicted that E2F1 was an upstream transcription factor of TNNC1, and further …
in HCC, we predicted that E2F1 was an upstream transcription factor of TNNC1, and further …
Fontan-Associated Liver Disease: A Review
110 天前 - … mild fibrosis to cirrhosis and hepatocellular carcinoma. The … Even invasive tissue
sampling is inconsistent due to the … -inducible factor 1-alpha and transforming growth factor-…
sampling is inconsistent due to the … -inducible factor 1-alpha and transforming growth factor-…
Bioactive Antiangiogenic Lipid Nanoparticles for Inhibiting Residual Tumor Growth after Insufficient Radiofrequency Ablation
W Luo, J Tan, X Chen, C Liu, W Zhang… - ACS Applied Nano …, 2024 - ACS Publications
116 天前 - … and minimally invasive … growth, migration, and tube formation for breast cancer
through Cut-like homeobox 1 (CUX1)/fibroblast growth factor 1 (FGF1)/hepatocyte growth factor (…
through Cut-like homeobox 1 (CUX1)/fibroblast growth factor 1 (FGF1)/hepatocyte growth factor (…
Abstract A043: Pericytes orchestrate a tumor-suppressive microenvironment by impinging on the crosstalk between macrophages and tumor-initiating cells in …
S Braun, C Oudenaarden, P Bolivar, J Sjölund… - Cancer Research, 2024 - AACR
119 天前 - … In the absence of pericytes, the recruited macrophages expressed Hepatocyte
Growth Factor (HGF), which reinforced activation of its receptor tyrosine kinase c-Met on a subset …
Growth Factor (HGF), which reinforced activation of its receptor tyrosine kinase c-Met on a subset …
Intensive Care of Cancer Patients
A Balakrishna, D Nahrwold, C Hughes - Anesthesia for Oncological …, 2024 - Springer
122 天前 - … growth, increasing risk factor exposure, and the advancing age of the population,
cancer cases and cancer deaths will continue to increase… after surgery or invasive procedures. …
cancer cases and cancer deaths will continue to increase… after surgery or invasive procedures. …
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
138 天前 - … Hence, identifying the biomarkers, the prognostic factors, … such as baseline
transforming growth factor beta, lactate … studies owing to its non-invasive, convenient, and highly …
transforming growth factor beta, lactate … studies owing to its non-invasive, convenient, and highly …